Overview
Iatrogenic hypoglycemia, often resulting from therapeutic interventions such as insulin administration or glucose-lowering medications, poses a significant clinical challenge. This condition can occur during the management of various metabolic disorders, including diabetes mellitus, and is particularly critical in hospitalized patients due to the complexity of their care regimens. While the provided evidence focuses more on iatrogenic arterial dissections rather than hypoglycemia, the principles of recognizing, diagnosing, and managing complications arising from medical interventions are analogous. This guideline aims to provide a comprehensive framework for clinicians dealing with iatrogenic complications, drawing parallels where applicable to ensure timely and effective patient care.
Clinical Presentation
Iatrogenic arterial dissections, as highlighted in the literature, can manifest acutely during endovascular procedures targeting intracranial aneurysms, both ruptured and unruptured [PMID:30803334]. These dissections often present with sudden neurological deficits, which can include focal motor or sensory disturbances, depending on the affected vascular territory. In the context of intracranial interventions, patients may exhibit symptoms such as severe headache, altered mental status, or even subarachnoid hemorrhage signs if the dissection leads to aneurysmal rupture or significant bleeding. Clinically, vigilance is crucial as these symptoms can mimic the underlying pathology or other complications, necessitating a high index of suspicion for dissection. Additionally, hemodynamic instability due to threatened flow arrest underscores the urgency of recognizing these signs for prompt intervention [PMID:30803334]. In clinical practice, a thorough neurological examination and imaging studies, such as computed tomography angiography (CTA) or magnetic resonance angiography (MRA), are essential for early detection and differentiation from other causes of neurological deterioration.
Diagnosis
Diagnosing iatrogenic arterial dissections involves a multifaceted approach, primarily relying on imaging modalities to visualize the extent and location of the dissection. The key diagnostic indicators, as observed in cases involving intracranial aneurysms, include the presence of intimal flaps, false lumens, and varying degrees of stenosis or occlusion on imaging studies [PMID:30803334]. These findings are critical for distinguishing dissections from other vascular pathologies such as aneurysms or occlusions. In clinical scenarios, the indication for urgent interventions like stent deployment is typically based on hemodynamic significance, where dissections threaten to compromise blood flow significantly enough to cause neurological deficits or threaten patient stability [PMID:30803334]. Furthermore, the development of pseudoaneurysms post-procedurally, as seen in cases involving the superior mesenteric artery (SMA), can be identified through imaging techniques like angiography, which may reveal aneurysmal dilations adjacent to the dissected segment [PMID:17086458]. Early and accurate diagnosis through these imaging modalities is pivotal for guiding timely therapeutic decisions.
Management
The management of iatrogenic arterial dissections often requires immediate and targeted interventions to restore blood flow and prevent further complications. In the context of intracranial dissections treated with Neuroform Atlas stents, immediate deployment has shown promising outcomes, with successful restoration of blood flow and complete reconstruction of the arterial lumen observed in multiple cases [PMID:30803334]. These stents not only stabilize the dissected segment but also mitigate the risk of intimal hyperplasia, maintaining patency over follow-up periods of 6-8 months. Similarly, the use of bare stents in managing dissecting pseudoaneurysms, such as those occurring post-angiography in the SMA, demonstrates another effective approach [PMID:17086458]. These stents provide structural support, preventing aneurysmal expansion and promoting healing of the dissected segment. In clinical practice, the choice of stent type (e.g., covered vs. bare) depends on the specific vascular location and the nature of the dissection, balancing the need for immediate stabilization with long-term patency and complication avoidance. Post-procedural monitoring through regular imaging and clinical assessments is essential to ensure continued vessel integrity and patient recovery.
Complications
Despite advancements in endovascular techniques, complications from iatrogenic arterial dissections remain a concern, albeit rare. These complications can include the formation of pseudoaneurysms, which pose significant risks such as rupture and hemorrhage [PMID:17086458]. The development of such complications underscores the necessity for meticulous procedural techniques and vigilant post-procedural monitoring. Clinicians must remain alert to subtle signs of ongoing dissection or pseudoaneurysm formation, as delayed diagnosis can lead to severe outcomes. Additionally, while not directly related to hypoglycemia, the principle of vigilance and proactive management applies similarly to other iatrogenic complications, emphasizing the importance of multidisciplinary care and continuous patient surveillance post-intervention.
Key Recommendations
These recommendations aim to guide clinicians in the timely and effective management of iatrogenic arterial dissections, ensuring optimal patient outcomes and minimizing complications.
References
1 Borota L, Mahmoud E, Nyberg C. Neuroform Atlas stent in treatment of iatrogenic dissections of extracranial internal carotid and vertebral arteries: a single-centre experience. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2019. link 2 Kutlu R, Ara C, Sarac K. Bare stent implantation in iatrogenic dissecting pseudoaneurysm of the superior mesenteric artery. Cardiovascular and interventional radiology 2007. link